Total n=189 | Advanced IIRC groups (D and E) n=153 (81%) | Enucleation n=134 (71%) | Adjuvant chemotherapy n=68 | |||||
n | % | n | % | n | % | n | % | |
Gender | ||||||||
Female | 91 | 48.1 | 73 | 48 | 64 | 48 | 36 | 53 |
Male | 98 | 51.8 | 80 | 52 | 70 | 52 | 32 | 47 |
Ethnicity | ||||||||
English/Scottish/Welsh | 140 | 74 | 110 | 71.8 | 98 | 73.1 | 54 | 79.4 |
Non-English/Scottish/Welsh | 48 | 25.4 | 42 | 27.4 | 35 | 26.1 | 14 | 20.5 |
Indian/Pakistani/Bangladesh | 23 | 12.1 | 21 | 13.7 | 18 | 13.4 | 9 | 13.2 |
Black Caribbean/African | 8 | 4.2 | 6 | 3.9 | 4 | 2.9 | 1 | 1.4 |
Mixed white | 11 | 5.8 | 9 | 5.8 | 8 | 5.9 | 1 | 1.4 |
Other white | 3 | 1.5 | 3 | 1.9 | 3 | 2.2 | 1 | 1.4 |
Other | 3 | 1.5 | 3 | 1.9 | 2 | 1.4 | 2 | 2.9 |
Not known | 1 | 0.5 | 1 | 0.6 | 1 | 0.7 | 0 | 0 |
IMD score (quintiles) | ||||||||
1 (most deprived) | 39 | 20.6 | 34 | 22.2 | 27 | 20.1 | 14 | 20.5 |
2 | 44 | 23.2 | 35 | 22.8 | 32 | 23.8 | 17 | 25.0 |
3 | 29 | 15.3 | 21 | 13.7 | 20 | 14.9 | 11 | 16.1 |
4 | 33 | 17.4 | 28 | 18.3 | 25 | 18.6 | 12 | 17.6 |
5 (least deprived) | 43 | 22.7 | 34 | 22.2 | 29 | 21.6 | 13 | 19.1 |
Not known | 1 | 1 | 1 | |||||
Age at diagnosis | ||||||||
<1 year | 71 | 37.5 | 52 | 33.9 | 41 | 30.5 | 27 | 39.7 |
1 to <2 years | 46 | 24.3 | 35 | 22.8 | 31 | 23.1 | 16 | 23.5 |
2 to <3 years | 32 | 16.9 | 29 | 18.9 | 28 | 20.8 | 10 | 14.7 |
3 to <4 years | 27 | 14.2 | 24 | 15.6 | 21 | 15.6 | 10 | 14.7 |
4 to 12 years | 13 | 6.8 | 13 | 8.4 | 13 | 9.2 | 5 | 7.3 |
Bilaterality | ||||||||
Unilateral | 130 | 68.7 | 103 | 67.3 | 97 | 72.3 | 35 | 51.4 |
Bilateral | 59 | 31.2 | 50 | 32.6 | 37 | 27.6 | 33 | 48.5 |
IIRC, International Intraocular Retinoblastoma Classification; IMD, Index of Multiple Deprivation.